David Berry joined the staff at Durham in December 2012 as a lecturer in Pharmaceutics, based at Queen’s Campus. David registered as a pharmacist in 2004 having completed his pre-registration training in hospital. He then worked as a junior pharmacist rotating through a number of clinical disciplines including oncology

Cancer Drug Discovery and Development Improvement of Poorly Soluble Drugs Solid State Pharmaceutics

Corner, Philip A., Harburn, J. Jonathan, Steed, Jonathan W., McCabe, James F. & Berry, David J. (2016). Stabilisation of an amorphous form of ROY through a predicted co-former interaction. Chemical Communications 52(39): 6537-6540. Nartowski, K. P., Khimyaka, Y. Z. & Berry, D. J. (2016). Tuning the spontaneous formation kinetics of caffeine malonic acid co-crystals. CrystEngComm 18(15): 2617-2620. Blagden, N., Coles, S.J. & Berry, D.J. (2014). Pharmaceutical co-crystals – are we there yet?. CrystEngComm 16(26): 5753-5761. Scott, J.S., Berry, D.J., Brown, H.S., Buckett, L., Clarke, D.S., Goldberg, K., Hudson, J.A., Leach, A.G., MacFaul, P.A., Rauboa, P. & Robb, G. (2013). Achieving improved permeability by hydrogen bond donor modulation in a series of MGAT2 inhibitors. MedChemComm 4(9): 1305-1311. Berry, D.J., Seaton, C.C., Clegg, W., Harrington, R.W., Coles, S.J., Horton, P.N., Hursthouse, M.B., Storey, R., Jones, W., Friscic, T. & Blagden, N. (2008). Applying hot-stage microscopy to co-crystal screening: a study of nicotinamide with seven active pharmaceutical ingredients. Crystal Growth and Design 8(5): 1697-1712. Blagden, N., Berry, D.J., Parkin, A., Javed, H., Ibrahim, A., Gavan, P.T., De Matos, L.L. & Seaton, C.C. (2008). Current directions in co-crystal growth. New Journal of Chemistry 32(10): 1659-1672.